SLC2A2
protein-codingsolute carrier family 2 member 2, the group of Solute carrier family 2
Gene summary
This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
- GLUT2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100164
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0016391
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0020525
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009216
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Endocrine; Gastrointestinal; Renal
Intervention: Biochemical; Endocrine
Rationale: Dietary measures (eg, frequent feeds, cornstarch) can be beneficial; In mildly affected individuals, dietary measures (eg, free glucose and galactose restriction) may be beneficial in terms of growth; Individuals may also manifest with neonatal diabetes mellitus, and awareness may allow preventive measures and prompt treatment related to severe episodes
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC2A2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000340.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 57 | 63 | |||
| missense | 2 | 9 | 134 | 10 | 2 | 157 |
| nonsense | 11 | 3 | 1 | 15 | ||
| start loss | 2 | 2 | ||||
| frameshift | 16 | 8 | 1 | 25 | ||
| splice donor/acceptor (+/-2bp) | 7 | 6 | 13 | |||
| Total | 38 | 26 | 142 | 67 | 2 | 275 |
Highest pathogenic variant AF is 0.000095297175
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000331.1 | 11 | MANE Select | |
| Ensembl | ENSP00000323568.3 | 11 | MANE Select | |
| RefSeq | NP_001265587.1 | 9 | Standard | |
| RefSeq | NP_001265588.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| slc2a2 | Danio rerio | Structure: whole organism Quality: dead abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Central carbon metabolism in cancer - Homo sapiens (human)
- Type II diabetes mellitus - Homo sapiens (human)
- Insulin resistance - Homo sapiens (human)
- Carbohydrate digestion and absorption - Homo sapiens (human)
- Maturity onset diabetes of the young - Homo sapiens (human)
Biological Process
- carbohydrate metabolic process
- hexose transmembrane transport
- regulation of insulin secretion
- dehydroascorbic acid transport
- intestinal hexose absorption
Molecular Function
- glucose transmembrane transporter activity
- hexose transmembrane transporter activity
- dehydroascorbic acid transmembrane transporter activity
- D-glucose transmembrane transporter activity
Cellular Component
- cytoplasm
- plasma membrane
- integral component of plasma membrane
- brush border
- cell-cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000314251
- Coding exons
- 11
- Length
- 30403
- Individuals with no LoFs
- 125696
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 52
- Defined
- 125748
- p
- 0.000207
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.936 | 227 | 270 | 0.840 | 0.0000134 | 3393 |
| Missense (PolyPhen) | 87 | 106.8 | 0.81461 | 1398 | ||
| Synonymous | 0.104 | 96 | 97.3 | 0.987 | 0.00000492 | 1061 |
| Loss of Function | 1.87 | 16 | 26.3 | 0.608 | 0.00000157 | 287 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00043 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00021 | 0.00021 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Facilitative glucose transporter. This isoform likely mediates the bidirectional transfer of glucose across the plasma membrane of hepatocytes and is responsible for uptake of glucose by the beta cells; may comprise part of the glucose-sensing mechanism of the beta cell. May also participate with the Na(+)/glucose cotransporter in the transcellular transport of glucose in the small intestine and kidney.;
- Disease
- DISEASE: Fanconi-Bickel syndrome (FBS) [MIM:227810]: Rare, well- defined clinical entity, inherited in an autosomal recessive mode and characterized by hepatorenal glycogen accumulation, proximal renal tubular dysfunction, and impaired utilization of glucose and galactose. {ECO:0000269|PubMed:10987651, ECO:0000269|PubMed:11044475}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.731
Intolerance Scores
- LoFtool
- 0.471
- RVIS EVS
- -0.22
- RVIS percentile EVS
- 37.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.736
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |